• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity & Inclusion
    • Pro Bono
    • Client Service Values
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Business Litigation
Labor & Employment
Blockchain, Smart Contracts & Digital Currencies
Coronavirus Resource Center
Cannabis
Corporate
Tax & Employee Benefits
Insurance Recovery, Litigation & Counseling
Government Investigations & White Collar Defense
Crisis Management
Intellectual Property
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Environment & Energy
Financial Institutions
Government Affairs
Government Contracts & Global Trade
Healthcare
Food & Beverage
Immigration
Impact Investing
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Proptech
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Energy & Utilities
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
Insights News Courtroom Podium
Main image for New Jersey High Court Fortifies “FDA Defense” in Failure-To-Warn Litigation
News

New Jersey High Court Fortifies “FDA Defense” in Failure-To-Warn Litigation

The Washington Legal Foundation

12.7.2018

The Washington Legal Foundation has published a legal opinion letter authored by partners Edward Fanning, David Kott, and Natalie Mantell, and associate Steven Del Mauro. Entitled “New Jersey High Court Fortifies ‘FDA Defense’ in Failure-to-Warn Litigation,” the letter discusses the New Jersey Supreme Court’s October 2018 decision on the presumption of adequacy for FDA approved warnings and choice-of-law in In re: Accutane Litigation. Ms. Mantell was counsel of record and a member of Roche’s litigation team in In Re: Accutane. Mr. Fanning and Mr. Kott represented The HealthCare Institute of New Jersey, co-authoring the amicus brief which Mr. Fanning argued before the New Jersey Supreme Court.

more information

sidebar

pdfemail

Related People

Media item: Edward J. Fanning, Jr.
Edward J. Fanning, Jr.

Partner

Media item: David R. Kott
David R. Kott

Partner

Media item: Natalie H. Mantell
Natalie H. Mantell

Partner

Related Services

Appellate
Products Liability, Mass Torts & Consumer Class Actions
Subscribe to our Insights
McCarter & English, LLP
Copyright © 2022 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel